Skip to content

13F-HR filed by ORACLE INVESTMENT MANAGEMENT INC

ORACLE INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2016-12-31, filed 2017-02-14, with 17 holding rows worth $602,930,000.

Accession
0001085146-17-000784
Filed
2017-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2016

A holdings report, 17 entries on the cover page, a total value of $602,930,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $602,930,000 with VALUE read as thousands by filing date, 13F file number 028-05592. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TESARO INC881569107COM1,248,086$167,843,000thousands by filing date
ACCELR8 TECHNOLOGY INC004304200COM5,032,389$104,422,000thousands by filing date
NXSTAGE MEDICAL INC67072V103COMMON STOCK2,721,636$71,334,000thousands by filing date
MAZOR ROBOTICS LTD57886P103SPONSORED ADS2,719,942$59,621,000thousands by filing date
QUIDEL CORP74838J101COM2,517,554$53,926,000thousands by filing date
OPKO HEALTH INC68375N103COM3,534,539$32,871,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW7,935,000$24,440,000thousands by filing date
PACIFIC BIOSCIENCES CALIF INC COM69404D108Stock5,516,894$20,964,000thousands by filing date
BIOLASE INC090911108COMMON STOCK14,622,050$20,471,000thousands by filing date
INTREXON CORP46122T102COM820,590$19,940,000thousands by filing date
VERMILLION INC92407M206COM NEW8,624,225$8,193,000thousands by filing date
AGENUS INC00847G101COM1,925,918$7,935,000thousands by filing date
ACCURAY INC DEL004397105COM1,490,879$6,858,000thousands by filing date
CONTRAFECT CORP212326102COM1,182,032$2,069,000thousands by filing date
BIOGEN INC COM09062X103Stock6,723$1,907,000thousands by filing date
SECOND SIGHT MED PRODS INC81362J100COM50,804$100,000thousands by filing date
ZIOPHARM ONCOLOGY INC98973P101COM6,661$36,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001085146-17-000784this filing2017-02-14acceptance time not in the bulk data set